MedPath

Extreme Large Core Infarct Stroke within 24 Hour Time Window: A Multi-center, Prospective, Chinese Cohort of Endovascular Thrombectomy in Acute Stroke

Not Applicable
Conditions
Acute ischemic stroke
Registration Number
ChiCTR2400088952
Lead Sponsor
The Second Affiliated Hospital of the Army Medical University
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Pending
Sex
All
Target Recruitment
Not specified
Inclusion Criteria
  1. Aged 18 years or over; <br>2. The time of arrival at the hospital is not more than 24 hours from the onset of stroke or the last normal time;<br>3. Clinical diagnosis of AIS due to anterior/posterior circulation large vessel occlusion on DSA/CTA/MRA; <br>4. Alberta Stroke Program Early CT Score (ASPECTS) <= 2 on CT/MRI; <br>5. National Institute of Health stroke scale (NIHSS) >= 3; <br>6. Informed consent obtained from patients or their legal representatives.<br>.
Exclusion Criteria

1.Confirmed intracranial hemorrhage through computed tomography (CT) or magnetic resonance imaging (MRI);<br>2.Pre-stroke modified Rankin Scale (mRS) score >= 2; <br>3.Pregnancy or breastfeeding women; <br>4.Genetic or acquired bleeding diathesis, deficiency of anticoagulant factors, or use of anticoagulant medication with an International Normalized Ratio (INR) > 3; 5.Presence of intracranial tumors with mass effect on imaging (excluding small meningiomas); <br>6.Any end-stage disease with expected survival less than 6 months; <br>7.Anticipated inability to complete follow-up; <br>8.Brain herniation causing midline shift; <br>9.Presence of severe complications that may affect patient prognosis and follow-up (cancer, severe heart failure, renal failure); <br>10. Suspected septic embolism or bacterial endocarditis;<br>11. Participating in other clinical trials;

Study & Design

Study Type
Observational study
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
The rate of 90-day modified Rankin scale (mRS) score 0-2(%);The rate of symptomatic intracerebral hemorrhage (SICH) at 48-hour and death at 90-day;
Secondary Outcome Measures
NameTimeMethod
The rate of 90-day modified Rankin scale (mRS) score 0-3(%);The rate of 90-day modified Rankin scale (mRS) score 0-1(%);Shift in the distribution of mRS scores at 90 days;EQ-5D score at 90 days;The rate of any type of intracranial hemorrhage at 48-hour;The rate of death at 7-day;
© Copyright 2025. All Rights Reserved by MedPath